HypoglycemiaGlucagonHyperglycemiaBlood GlucoseInsulinHypoglycemic AgentsDiabetes Mellitus, Type 1Receptors, GlucagonEpinephrineHyperinsulinismGlucosePancreatic PolypeptideGlucose Clamp TechniqueHemoglobin A, GlycosylatedBlood Glucose Self-MonitoringInsulin Infusion SystemsInsulin, Long-ActingDiabetes Mellitus, Type 2Insulin ComaClinical AlarmsC-PeptideVentromedial Hypothalamic NucleusGlucagon-Secreting CellsGluconeogenesisHydrocortisoneDiabetes Mellitus, ExperimentalNesidioblastosisIslets of LangerhansCongenital HyperinsulinismSulfonylurea CompoundsInsulinomaDiabetes MellitusTime FactorsFastingNorepinephrinePancreas, ArtificialLiverGlucose Tolerance Test3-Hydroxybutyric AcidGlipizideSomatostatinInsulin AntibodiesGlucagon-Like Peptide 1Treatment OutcomeDiazoxideAwarenessFatty Acids, NonesterifiedHomeostasisPancreasAdenoma, Islet CellInsulin LisproMonitoring, AmbulatoryInfusions, SubcutaneousPostprandial PeriodInsulin AspartAutonomic Nervous SystemHuman Growth HormoneInsulin, IsophanePancreatectomyStreptozocinHormonesSeverity of Illness IndexLactatesInfant, NewbornLiver GlycogenInfusions, IntravenousProglucagonInsulin, Regular, PorkRisk FactorsLactic AcidDipeptidyl-Peptidase IV InhibitorsGlucokinaseRetrospective StudiesRats, Sprague-DawleyInsulin-Secreting CellsPure Autonomic FailureMetforminPregnancy in DiabeticsCritical IllnessReference ValuesAdrenocorticotropic HormoneDumping SyndromeBrainVenomsGrowth HormoneDiabetic KetoacidosisDepressionGlycogenSulfonylurea ReceptorsSymptom AssessmentProspective StudiesGlucagon-Like PeptidesQuestionnairesMonitoring, PhysiologicGlycerolFactitious DisordersHydroxybutyratesInfant, Newborn, DiseasesDiabetic ComaDiabetes Complications